Table 1: General, anthropometric, and biochemical parameters of the subjects.

ControlsNAFLD without diabetesNAFLD with diabetes value

Age (years)37.9 ± 8.441.8 ± 7.342.9 ± 7.60.04
NAFLD Grades I, II, and III ()15, 10, 016, 8, 10.62
Variables related to whole body fat
BMI (kg/m2)24.20.0001
(21.7–26.6)(24.8–31.2)(25.7–30.1)
WHR0.95 ± 0.11.0 ± 0.10.052
Fat percentage (%)24.0 ± 6.726.6 ± 7.00.001
Fat mass (kg)15.4 ± 5.60.002
Variables related to inflammation
ESR (mm/hr)12.018.00.020
(8.5–19.0)(12.0–28.5)(10.5–33.5)
hsCRP (mg/L)6.78.00.007
(1.5–12.3)(9.6–13.0)(4.0–12.0)
Variables related to liver function
Bilirubin (mg/dL)0.60.50.50.916
(0.4–0.8)(0.4–0.8)(0.3–0.8)
SGOT (AST) (IU/L)25.030.027.00.354
(21.5–31.0)(22.0–44.5)(22.0–44.5)
SGPT (ALT) (IU/L)25.036.036.00.111
(18.5–36.0)(23.0–57.0)(23.0–51.5)
ALP (IU/L)180.0204.0189.00.545
(158.5–213.5)(165.0–250.0)(154.0–229.5)
Variables related to lipid profile
TG (mg/dL)132.0140.0161.00.228
(81.0–173.5)(98.5–222.0)(115.5–201.5)
TC (mg/dL)168.0191.00.005
(144.0–196.5)(162.5–235.5)(171.5–230.0)
LDL (mg/dL)100.0117.00.009
(82.5–126.0)(99.0–138.0)(102.0–148.5)
HDL (mg/dL)44.045.046.00.423
(40.5–49.5)(40.5–47.5)(41.0–53.5)
VLDL (mg/dL)20.00.003
(16.0–26.5)(19.5–42.0)(23.5–43.5)
Variables related to diabetic status
FBG (mg/dL)89.097.00.0001
(86.0–95.0)(90.5–101.0)(109.5–164.0)
PPBG (mg/dL)119.0129.00.0001
(104.0–128.0)(118.5–142.0)(154.5–218.5)
Fasting insulin (µIU/mL)10.515.611.40.323
(5.9–17.2)(5.4–20.7)(10.0–17.2)
HOMA-IR
2.03.80.0001
(1.3–4.0)(1.3–5.1)(2.6–5.5)

Values are expressed as median (IQR) or mean ± SD; versus control; versus NAFLD without diabetes.
BMI: Body Mass Index; WHR: Waist Hip Ratio; ESR: Erythrocyte Sedimentation Rate; hsCRP: High-Sensitivity C Reactive Protein; SGOT: Serum Glutamic Oxaloacetic Transaminase; AST: Aspartate Transaminase; SGPT: Serum Glutamate Pyruvate Transaminase; ALT: Alanine Transaminase; ALP: Alkaline Phosphatase; IU: International Unit; TG: Triglycerides; TC: total cholesterol; LDL: Low Density Lipoprotein; HDL: High Density Lipoprotein; VLDL: Very Low Density Lipoprotein; FBG: fasting blood glucose; PPBG: postprandial blood glucose; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance.